Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sandoz' Clozaril

Executive Summary

More than 40 state Medicaid agencies now cover the antischizophrenic agent (clozapine), the firm announced April 23. "Many" states decided to provide reimbursement for Clozaril therapy since April 1, when Sandoz announced availability of the drug through normal wholesale channels ("The Pink Sheet" April 1, T&G-2 and April 15, T&G-6) .... Norplant Foundation: Wyeth- Ayerst is providing $ 2.8 mil. to establish a foundation assisting women who could not otherwise afford the implanted contraceptive. Program will be directed by Philip Darney, MD, San Francisco General Hospital Family Planning Clinic director. The five-year Norplant System costs about $ 350, including certain equipment needed to implant the product ("The Pink Sheet" Feb. 11, In Brief). Wyeth Ayerst said 23 state Medicaid agencies now cover Norplant.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS019125

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel